STK38 anticorps (C-Term)
Aperçu rapide pour STK38 anticorps (C-Term) (ABIN634342)
Antigène
Voir toutes STK38 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- STK38 antibody was raised against the C terminal of STK38
-
Purification
- Affinity purified
-
Immunogène
- STK38 antibody was raised using the C terminal of STK38 corresponding to a region with amino acids IGAPGVEEIKSNSFFEGVDWEHIRERPAAISIEIKSIDDTSNFDEFPESD
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
STK38 Blocking Peptide, (ABIN939352), is also available for use as a blocking control in assays to test for specificity of this STK38 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of STK38 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- STK38 (serine/threonine Kinase 38 (STK38))
-
Autre désignation
- STK38
-
Sujet
- STK38 belongs to the protein kinase superfamily, AGC Ser/Thr protein kinase family. It contains 1 AGC-kinase C-terminal domain and 1 protein kinase domain. NDR-driven centrosome duplication requires Cdk2 activity and that Cdk2-induced centrosome amplification is affected upon reduction of NDR activity.
-
Poids moléculaire
- 54 kDa (MW of target protein)
Antigène
-